Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate cancer, Medicine, Docetaxel, Olaparib, Cohort, and Glutamate carboxypeptidase II.
612P Pembrolizumab (pembro) plus olaparib in patients with docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): Update of KEYNOTE-365 cohort A with a minimum of 11 months of follow-up for all patients
An IgG‐based bispecific antibody for improved dual targeting in PSMA‐positive cancer
621P Pembrolizumab (pembro) plus olaparib in patients (pts) with docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort A update
217O Pembrolizumab (pembro) combination therapies in patients with metastatic castration-resistant prostate cancer (mCRPC): Cohorts A-C of the phase Ib/II KEYNOTE-365 study